[Prevention of thrombo-embolic complications in urology using sub-cutaneous calcium heparinate (author's transl)].
Thrombo-embolic complications remain one of major preoccupations of surgery. As well as their treatment, prevention is of even greater importance. Following a discussion of the physiopathology of coagulation in the patient undergoing surgery, the authors study those factors peculiar to urology. Despite the risk of haemorrhage involved in such surgery, 158 patients underwent operation after having received anticoagulants in the form of sub-cutaneous calcium heparinate even before the procedure. The decrease in the number of thrombo-embolic complications appeared to confirm the effectiveness of this therapeutic measure.
D000367:Age Factors; D000368:Aged; D001777:Blood Coagulation; D006470:Hemorrhage / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007103:Immobilization; D007239:Infections / Q000209:etiology; D007674:Kidney Diseases / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D011469:Prostatic Diseases / Q000601:surgery; D012306:Risk; D013923:Thromboembolism / Q000517:prevention & control*; D013997:Time Factors; D001745:Urinary Bladder Diseases / Q000601:surgery; D014570:Urologic Diseases / Q000601:surgery
D006493:Heparin
La prévention du risque thrombo-embolique en urologie par l'héparinate de calcium en sous-cutané